- Home
- IPI vs ENGN Comparison
IPI vs ENGN Comparison
Compare IPI & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPI
- ENGN
- Stock Information
- Founded
- IPI 2000
- ENGN 1999
- Country
- IPI United States
- ENGN Canada
- Employees
- IPI N/A
- ENGN N/A
- Industry
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- ENGN
- Sector
- IPI Industrials
- ENGN
- Exchange
- IPI Nasdaq
- ENGN Nasdaq
- Market Cap
- IPI 518.6M
- ENGN 204.3M
- IPO Year
- IPI 2008
- ENGN N/A
- Fundamental
- Price
- IPI $35.87
- ENGN $3.62
- Analyst Decision
- IPI Strong Sell
- ENGN Buy
- Analyst Count
- IPI 1
- ENGN 7
- Target Price
- IPI $19.00
- ENGN $23.29
- AVG Volume (30 Days)
- IPI 166.7K
- ENGN 93.9K
- Earning Date
- IPI 08-04-2025
- ENGN 06-12-2025
- Dividend Yield
- IPI N/A
- ENGN N/A
- EPS Growth
- IPI N/A
- ENGN N/A
- EPS
- IPI N/A
- ENGN N/A
- Revenue
- IPI $217,865,000.00
- ENGN N/A
- Revenue This Year
- IPI $11.06
- ENGN N/A
- Revenue Next Year
- IPI N/A
- ENGN N/A
- P/E Ratio
- IPI N/A
- ENGN N/A
- Revenue Growth
- IPI N/A
- ENGN N/A
- 52 Week Low
- IPI $20.75
- ENGN $2.65
- 52 Week High
- IPI $39.01
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- IPI 47.32
- ENGN 53.03
- Support Level
- IPI $34.20
- ENGN $2.95
- Resistance Level
- IPI $36.37
- ENGN $3.44
- Average True Range (ATR)
- IPI 1.33
- ENGN 0.27
- MACD
- IPI -0.25
- ENGN 0.06
- Stochastic Oscillator
- IPI 37.69
- ENGN 92.31
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.